Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nuclear ribonucleoprotein polypeptide C pseudogene 11 (SNRPCP11) is classified as a **pseudogene**, which is a DNA sequence similar to a functional gene (in this case, small nuclear ribonucleoprotein polypeptide C, or SNRPC) that has acquired mutations rendering it nonfunctional as a protein-coding gene. Pseudogenes are common in the human genome and may occasionally have regulatory functions through RNA transcripts, but there is no evidence that SNRPCP11 has any biological function, involvement in disease, or role as a therapeutic target. It is not a member of any known receptor, enzyme, transporter, or other clinically relevant protein families, nor is it used as a biomarker or targeted by any approved drugs[3][4]. *Note: Although some pseudogenes can have functional regulatory RNAs and rare examples are shown to affect disease biology, there is no evidence supporting such a role for SNRPCP11 at this time. If you are seeking a functionally relevant target, this entry is not suitable.*
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide C pseudogene 11 (SNRPCP11).